MC2274A1 - Formes d'application solides pour la voie orale qui contiennent de l'ifosfamide comme substance active - Google Patents

Formes d'application solides pour la voie orale qui contiennent de l'ifosfamide comme substance active

Info

Publication number
MC2274A1
MC2274A1 MC912206A MC2206A MC2274A1 MC 2274 A1 MC2274 A1 MC 2274A1 MC 912206 A MC912206 A MC 912206A MC 2206 A MC2206 A MC 2206A MC 2274 A1 MC2274 A1 MC 2274A1
Authority
MC
Monaco
Prior art keywords
active substance
solid oral
forms containing
application forms
oral application
Prior art date
Application number
MC912206A
Other languages
English (en)
French (fr)
Inventor
Dieter Sauerbier Mm
Engel Juergen
Milsmann Eckhard
Molge Klaus
Isaac Otto
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of MC2274A1 publication Critical patent/MC2274A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
    • A61K9/2846—Poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4866—Organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MC912206A 1990-08-03 1991-07-24 Formes d'application solides pour la voie orale qui contiennent de l'ifosfamide comme substance active MC2274A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4024683 1990-08-03
SG181694A SG181694G (en) 1990-08-03 1994-12-30 Solid oral administration forms containing ifosfamide as active agent

Publications (1)

Publication Number Publication Date
MC2274A1 true MC2274A1 (fr) 1993-06-23

Family

ID=25895607

Family Applications (1)

Application Number Title Priority Date Filing Date
MC912206A MC2274A1 (fr) 1990-08-03 1991-07-24 Formes d'application solides pour la voie orale qui contiennent de l'ifosfamide comme substance active

Country Status (33)

Country Link
US (1) US5158776A (pt)
EP (1) EP0469440B1 (pt)
JP (2) JP3061898B2 (pt)
KR (1) KR0177170B1 (pt)
CN (1) CN1046851C (pt)
AR (1) AR247484A1 (pt)
AT (1) ATE110261T1 (pt)
AU (2) AU643309B2 (pt)
BG (1) BG60900B1 (pt)
CA (1) CA2048367C (pt)
CZ (1) CZ280475B6 (pt)
DE (2) DE59102620D1 (pt)
DK (1) DK0469440T3 (pt)
EG (1) EG19690A (pt)
ES (1) ES2058999T3 (pt)
FI (1) FI97951C (pt)
HK (1) HK15695A (pt)
HR (1) HRP920575B1 (pt)
HU (1) HU206268B (pt)
IE (1) IE66378B1 (pt)
IL (1) IL99031A (pt)
LT (1) LT3528B (pt)
LV (1) LV10043B (pt)
MC (1) MC2274A1 (pt)
MX (1) MX9100441A (pt)
NO (1) NO178252C (pt)
NZ (1) NZ239222A (pt)
PT (1) PT98532B (pt)
RO (1) RO113611B1 (pt)
SG (1) SG181694G (pt)
SI (1) SI9111342B (pt)
SK (2) SK279740B6 (pt)
ZA (1) ZA916124B (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
ITFI970184A1 (it) * 1997-07-30 1999-01-30 Menarini Farma Ind Composizioni farmaceutiche contenenti vitamina d e calcio,loro preparazione ed uso terapeutico
DE19733305A1 (de) * 1997-08-01 1999-02-04 Asta Medica Ag Pharmazeutische Zusammensetzung enthaltend Ifosfamid und Carnitin
US6103297A (en) * 1998-01-14 2000-08-15 Matsushita Electronics Corporation Method of manufacturing cathode-ray tube
DE19826517B4 (de) * 1998-06-15 2006-03-23 Baxter Healthcare S.A. Verfahren zur Herstellung von Filmtabletten mit Cyclophosphamid als Wirkstoff und daraus hergestellte Cyclophosphamid-Filmtablette
US20040253307A1 (en) * 2003-02-04 2004-12-16 Brian Hague Sugar-free oral transmucosal solid dosage forms and uses thereof
DE102005008797A1 (de) * 2005-02-25 2006-09-07 Baxter International Inc., Deerfield Trofosfamid-haltige Filmtabletten und Verfahren zu deren Herstellung
ES2785391T3 (es) * 2014-01-06 2020-10-06 Shield Tx Uk Ltd Régimen de dosificación de trimaltol férrico
GB201418710D0 (en) 2014-10-21 2014-12-03 Iron Therapeutics Holdings Ag Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5646807A (en) * 1979-09-27 1981-04-28 Japan Atom Energy Res Inst Production of composition of complex gradually releasing physiologically active substance
DE3111428A1 (de) * 1981-03-24 1982-10-07 Asta-Werke Ag, Chemische Fabrik, 4800 Bielefeld Oxazaphosphorin-4-thio-alkansulfonsaeuren und deren neutrale salze, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
US4618692A (en) * 1981-09-03 1986-10-21 Asta-Werke Aktiengesellschaft 4-carbamoyloxy-oxazaphosphorins
US5019385A (en) * 1984-11-09 1991-05-28 Kabushiki Kaisha Hayashibara Seibutsu Kagaku Kenkyujo Novel lymphopine LK 2 and pharmaceutic compositions containing same
EP0254902B1 (de) * 1986-07-11 1991-08-28 ASTA Pharma Aktiengesellschaft Lösungen von Oxazaphosphorinen mit verbesserter Stabilität und Verfahren zu deren Herstellung
DE3804686A1 (de) * 1988-02-15 1989-08-24 Henkel Kgaa Arzneimittel mit einer kombination von cytostatika bzw. hormontherapeutika und phosphonoderivaten

Also Published As

Publication number Publication date
IE66378B1 (en) 1995-12-27
NZ239222A (en) 1993-01-27
AU649184B2 (en) 1994-05-12
SK279740B6 (sk) 1999-03-12
KR920003963A (ko) 1992-03-27
IE912774A1 (en) 1992-02-12
JP3545300B2 (ja) 2004-07-21
BG60900B1 (bg) 1996-06-28
FI913710A0 (fi) 1991-08-02
SG181694G (en) 1995-05-12
EP0469440A1 (de) 1992-02-05
IL99031A (en) 1996-09-04
DK0469440T3 (da) 1994-11-14
NO913019L (no) 1992-02-04
HUT59316A (en) 1992-05-28
AU8158991A (en) 1992-02-06
PT98532B (pt) 1999-01-29
FI97951B (fi) 1996-12-13
SK279739B6 (sk) 1999-03-12
DE59102620D1 (de) 1994-09-29
LV10043B (en) 1995-06-20
US5158776A (en) 1992-10-27
HRP920575B1 (en) 1999-04-30
LTIP921A (en) 1995-03-27
RO113611B1 (ro) 1998-09-30
FI97951C (fi) 1997-03-25
NO178252B (no) 1995-11-13
ZA916124B (en) 1992-04-29
ES2058999T3 (es) 1994-11-01
CS240991A3 (en) 1992-03-18
DE4124481A1 (de) 1992-02-06
FI913710A (fi) 1992-02-04
HU206268B (en) 1992-10-28
CA2048367A1 (en) 1992-02-04
PT98532A (pt) 1992-06-30
CA2048367C (en) 2000-05-23
MX9100441A (es) 1992-04-01
IL99031A0 (en) 1992-07-15
EG19690A (en) 1995-09-30
HU912594D0 (en) 1992-01-28
CN1046851C (zh) 1999-12-01
CN1058715A (zh) 1992-02-19
LT3528B (en) 1995-11-27
HRP920575A2 (en) 1995-04-30
ATE110261T1 (de) 1994-09-15
SI9111342A (sl) 1998-04-30
CZ280475B6 (cs) 1996-01-17
KR0177170B1 (ko) 1999-03-20
JP2000229860A (ja) 2000-08-22
AR247484A1 (es) 1995-01-31
EP0469440B1 (de) 1994-08-24
NO913019D0 (no) 1991-08-02
BG94934A (bg) 1993-12-24
AU4483693A (en) 1993-11-11
HK15695A (en) 1995-02-10
JP3061898B2 (ja) 2000-07-10
NO178252C (no) 1996-02-21
JPH04243828A (ja) 1992-08-31
AU643309B2 (en) 1993-11-11
LV10043A (lv) 1994-05-10
SI9111342B (sl) 1998-10-31

Similar Documents

Publication Publication Date Title
LU90115B1 (fr) Formulation orale de 2-méthyl-thiéno-benzodiazépine
FR2737122B1 (fr) Composition stable contenant de l'acide ascorbique
FI941396A0 (fi) Koostumuksia biologisesti aktiivisen TGF-valvottua vapauttamista varten
IT1246188B (it) Procedimento per la preparazione di composizioni farmaceutiche aventi aumentata velocita' di dissoluzione della sostanza attiva e composizioni ottenute.
DE69612977D1 (de) Amorphe kieselsäuren und orale zusammensetzungen
IT1155990B (it) Disposizione per la registrazione d'immagini particolarmente in facsimile
PT754407E (pt) Formulacoes liquidas de 1,2-benzisotiazolin-3-ona
MA22946A1 (fr) Compositions de precurseurs d'agents de blanchiment.
IT1295645B1 (it) Apparecchio per l'elettroemanazione di principi attivi.
IL117050A0 (en) Solid active ingredient compositions containing hydroxypropylcellulose
FR2754177B1 (fr) Microspheres pharmaceutiques d'acide valproique pour administration orale
MC2274A1 (fr) Formes d'application solides pour la voie orale qui contiennent de l'ifosfamide comme substance active
IT1272924B (it) Procedimento per la preparazione di composti ciclopentadienilici e composti cosi' ottenibili
TR199701051A3 (tr) 2' -Fluoro-5-metil- -l-arabino-furanosilüridin hazirlanma prosesi
FR2737952B1 (fr) Batterie de cages pour l'aviculture
FR2678836B1 (fr) Formulations pour voie orale d'ubidecarenone sous la forme de solutions aqueuses.
FR2744648B1 (fr) Procede de preparation d'agents tensioactifs
IT9047924A0 (it) Composizione per l'igiene orale.
ITMI910504A0 (it) Disponibilita' di micro-elementi per piante
MD283F1 (ro) Compozitie de ingrediente pentru balsamul tonifiant "legenda"
ITMI913510A1 (it) Composizioni farmaceutiche contenenti progesterone ad elevata biodisponibilita'
FR2677250B1 (fr) Compositions pharmaceutiques contenant de l'adenosine-5-triphosphate disodique.
FR2541114B1 (fr) Compositions pharmaceutiques antifongiques utilisables par voie orale contenant de l'omoconazole
FR2684848B1 (fr) Utilisation du glucomannane pour la preparation d'une gelee orale a effet de satiete et gelee orale comprenant du glucomannane a effet de satiete ainsi obtenue.
FR2738503B1 (fr) Catalyseur solides d'alkylation aliphatique